Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
McGill University Health Centre/Research Institute of the McGill University Health Centre
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Symptomatic adult patients positive by PCR for COVID-19 within 5 days of enrollment with fever, cough, or shortness of breath. Provision of Informed Consent
At day 0, patients should be at home
You may not be if
Already on inhaled corticosteroid medication
Currently using systemic steroids (oral or intravenous or intramuscular such as Prednisone) or use of steroids 7 days prior to enrolment
Severely ill patients at enrollment (i.e., admitted to ICU at admission)
Unable to self-administer the inhaler
Known or suspected pregnancy and breastfeeding
Known allergy to study medication or its components (non-medicinal ingredients; including lactose allergy (type I))
Patients with untreated fungal, bacterial, or tubercular infections of the respiratory tract
